Return to content in this issue

Mepolizumab for the Treatment of Eosinophilic Granulomatosis With Polyangiitis: Our Experience

Díaz-Campos RM^1*, Prudencio-Ribera VC^1*, García- Moguel I², Fernández-Rodríguez C², Corral-Blanco M¹, Jarrin- Estupiñan ME¹, Melero-Moreno C<sup>3

1</sup>Severe Asthma Unit. Pneumology Service, Hospital Universitario 12 de Octubre, Madrid, Spain
²Severe Asthma Unit. Allergology Service, Hospital Universitario 12 de Octubre, Madrid, Spain
³Institute for Health Research (i+12), Hospital Universitario 12 de Octubre, Madrid, Spain
^*These authors contributed equally to this manuscript.

J Investig Allergol Clin Immunol 2019; Vol 29(5) : 384-385
doi: 10.18176/jiaci.0407

• Abstract
• Supplemental Materials

Key words: Asthma, Vasculitis, Eosinophilia, IL-5, Mepolizumab

	Title	Type	Size
	doi10.1876_jiaci.0407_material-suppl.pdf	pdf	280.33 Kb